Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kanz

Showing results (51-60 of 241) with videos related to

Pageof 25
Sort By:
World Journal of Urology|May 26, 2001
Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapyC Kollmannsberger, F Mayer, M Kuczyk, et al.
Experimental Hematology|June 1, 1988
Detection of messenger RNAs within single hemopoietic cells by in situ hybridization on small slide areasL Kanz, R Mielke, G W Löhr, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
UFT/calcium folinate plus weekly paclitaxel for solid tumorsC Bokemeyer, J T Hartmann, C Kollmannsberger, et al.
Seminars in Hematology|July 31, 1998
Ex vivo expansion of hematopoietic progenitor cells for clinical useS Scheding, K Kratz-Albers, B Meister, et al.
The New England Journal of Medicine|August 3, 1995
Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivoW Brugger, S Heimfeld, R J Berenson, et al.
International Journal of Cell Cloning|July 1, 1991
The role of cytokines in oncologyW Lange, W Brugger, F M Rosenthal, et al.
Blut|August 1, 1982
Suppressor T-cell clones derived from pluripotent stem cells (CFU-GEMM) of a patient with Hodgkin's lymphomaA A Fauser, K G Bross, L Kanz, et al.
Seminars in Hematology|March 16, 2000
Ex vivo manipulation of hematopoietic stem and progenitor cellsW Brugger, S Scheding, B Ziegler, et al.
Seminars in Oncology|April 1, 1992
Role of hematopoietic growth factor combinations in experimental and clinical oncologyW Brugger, K J Bross, A Lindemann, et al.
The Journal of Clinical Investigation|March 1, 1985
T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemiaA A Fauser, L Kanz, K J Bross, et al.
Pageof 25

Showing results (51-60 of 241) with videos related to

Sort By:
Pageof 25
World Journal of Urology|May 26, 2001
Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapyC Kollmannsberger, F Mayer, M Kuczyk, et al.
Experimental Hematology|June 1, 1988
Detection of messenger RNAs within single hemopoietic cells by in situ hybridization on small slide areasL Kanz, R Mielke, G W Löhr, et al.
Oncology (Williston Park, N.Y.)|August 12, 1999
UFT/calcium folinate plus weekly paclitaxel for solid tumorsC Bokemeyer, J T Hartmann, C Kollmannsberger, et al.
Seminars in Hematology|July 31, 1998
Ex vivo expansion of hematopoietic progenitor cells for clinical useS Scheding, K Kratz-Albers, B Meister, et al.
The New England Journal of Medicine|August 3, 1995
Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivoW Brugger, S Heimfeld, R J Berenson, et al.
International Journal of Cell Cloning|July 1, 1991
The role of cytokines in oncologyW Lange, W Brugger, F M Rosenthal, et al.
Blut|August 1, 1982
Suppressor T-cell clones derived from pluripotent stem cells (CFU-GEMM) of a patient with Hodgkin's lymphomaA A Fauser, K G Bross, L Kanz, et al.
Seminars in Hematology|March 16, 2000
Ex vivo manipulation of hematopoietic stem and progenitor cellsW Brugger, S Scheding, B Ziegler, et al.
Seminars in Oncology|April 1, 1992
Role of hematopoietic growth factor combinations in experimental and clinical oncologyW Brugger, K J Bross, A Lindemann, et al.
The Journal of Clinical Investigation|March 1, 1985
T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemiaA A Fauser, L Kanz, K J Bross, et al.
Pageof 25